ACMA Liver Cancer Treatment

ACMA Liver Cancer Treatment

ACMA Liver Cancer Treatment

—More effective and safer than conventional cancer treatments

Leading cancer treatment in the United States, which enables stage I, II, and III cancer patients to become cancer free without surgery, chemo, or radiotherapy. ACMA treatments are safe, natural, herbal medicines that are effective alternatives to conventional treatments. To order ACMA Liver Cancer Treatment, see instructions below.

  1. If you are a new patient, complete the ACMA Diagnosis Form first. Ordering instructions will follow. If you would like to discuss your case with the doctor first, schedule a consultation here for the Chicago area. If outside of the Chicago area, Contact Us to schedule a FREE 15 minute phone consultation with the doctor within the US (if outside of the US, other contact arrangements can be made).
  2. If you are an existing ACMA patient, you can follow previous ACMA treatment instructions to reorder and take the treatments.
  3. The price for treatment is below, plus tax and shipping. Credit card payment type is accepted.
    1 Week Supply $200 $150
    2 Week Supply $400 $300
    4 Week Supply $800 $600
  4. After you order ACMA products, we will send the products to you with detailed instruction within 3 business days.
  5. The product shelf life is 1 year from the time when you place the order.
  6. After receiving the products, please follow the instruction exactly to take the treatments.
  7. Please Contact Us if you have any questions or meet any problems when taking the treatments.
  8. After taking the treatments, if your conditions start improving, please continue the treatments as instructed.
  9. If you get allergic reactions, or if your conditions get worse, please Contact Us ASAP.
  10. During the treatments, please do lab testing based on your need (every month, every 3 months, or every 6 months, etc.), and send us the lab reports asap when they are available.

Liver cancer is cancer that begins in the cells of your liver. Your liver is a football-sized organ that sits in the upper right portion of your abdomen, beneath your diaphragm, and above your stomach.

The most common form of liver cancer is hepatocellular carcinoma, which begins in the main type of liver cell (hepatocyte). Other types of cells in the liver can develop cancer, but these are much less common.

Not all cancers that affect the liver are considered liver cancer. Cancer that begins in another area of the body — such as the colon, lung, or breast — and then spreads to the liver is called metastatic cancer rather than liver cancer. And this type of cancer is named after the organ in which it began — such as metastatic colon cancer to describe cancer that begins in the colon and spreads to the liver.

Liver cancer is a very aggressive cancer. Under allopathic medicine cancer treatments (surgery, chemo therapy, radiation therapy, etc.), liver cancer patients usually have a poor prognosis with an average life duration of a few months accompanied by progressively deteriorated conditions.

According to the World Health Organization (WHO), in 1990 there were about 430,000 new cases of liver cancer worldwide, and a similar number of liver cancer patients died. So liver cancer is a deadly cancer that will kill almost all patients who have it within a year. The average life span of liver cancer patients is about 4 to 6 months.


It is not clear what causes most cases of liver cancer. But in some cases, the cause is known. For instance, chronic infection with certain hepatitis viruses can cause liver cancer.

Primary liver cancer (hepatocellular carcinoma) tends to occur in livers damaged by birth defects, alcohol abuse, or chronic infection with diseases such as hepatitis B and C, hemochromatosis (a hereditary disease associated with too much iron in the liver), and cirrhosis. More than half of all people diagnosed with primary liver cancer have cirrhosis — a scarring condition of the liver commonly caused by alcohol abuse. Hepatitis B and C and hemochromatosis can cause permanent damage and liver failure. Liver cancer may also be linked to obesity and fatty liver disease.

Various cancer-causing substances are associated with primary liver cancer, including certain herbicides and chemicals such as vinyl chloride and arsenic. Smoking, especially if you abuse alcohol as well, also increases risk. Aflatoxins, cancer-causing substances made by a type of plant mold, have also been implicated. Aflatoxins can contaminate wheat, peanuts, rice, corn, and soybeans. These are rare problems in most developed countries like the U.S. Other causes include the hormones androgen and estrogen and a dye formerly used in medical tests called thorotrast.

Other risk factors for liver cancer may include:

  • Your sex. Men are more likely to get hepatocellular carcinoma than women.
  • Your weight. Obesity can increase the risk for hepatocellular carcinoma.
  • Your race. In the U.S., liver cancer is most common in Asian Americans and Pacific Islanders.
  • Anabolic steroid use. Male hormones abused by athletes to increase muscle can slightly increase liver cancer risk with long-term use.
  • History of diabetes. Studies have suggested a link between diabetes and liver cancer. This is likely due to the link between diabetes and fatty liver disease.
  • Inherited metabolic diseases. Diseases that disrupt the normal metabolism of the body have been shown to increase your risk of liver cancer.
  • Rare diseases. Studies have found a link between liver cancer and some rare diseases like alpha-1 antitrypsin deficiency, tyrosinemia, and Wilson’s disease.

Most people do not have signs and symptoms in the early stages of primary liver cancer. When signs and symptoms do appear, they may include:

  • Losing weight without trying
  • Loss of appetite
  • Upper abdominal pain
  • Nausea and vomiting
  • General weakness and fatigue
  • Abdominal swelling
  • Yellow discoloration of your skin and the whites of your eyes (jaundice)
  • White, chalky stools

Comparison of Orthodox Cancer Treatments and ACMA Cancer Treatments

Orthodox Cancer Treatments ACMA Cancer Treatments
Kills far more normal cells than cancerous cells. ACMA treatments selectively kill cancerous cells, either directly or indirectly, and do no harm to normal cells.
Severely damages organs and the immune system. ACMA treatments do not damage organs and the immune system.
Can destroy the functions of key organs, such as the liver, heart, kidney, etc., leading to death due to side effects. Do not damage any key organs as long as patients follow ACMA treatment instructions.
Damage the gastrointestinal system, cause sick feeling, nausea, vomiting, and lost appetite, or death due to malnutrition. ACMA treatments do not have any side effect.
Patients die of infectious diseases caused by a weakened immune system due to chemo and radiotherapy. ACMA treatments can protect patients from getting infectious diseases.
One side effect that chemotherapy has is that it can cause new cancer. ACMA cancer treatments do not have any side effect causing new cancer. On the contrary, ACMA cancer treatment can prevent new cancer from developing or growing.
For many cancer patients, orthodox treatments cause them died earlier comparing to no treatment at all for many types of cancer. For most ACMA cancer patients, ACMA cancer treatments have extended their lives, including extending the lives of cancer patients who were sent hospice after orthodox medicine failed to help them.
Can do significant damage to DNA and causing new cancer. ACMA cancer treatments do not cause damage to DNA as long as patients follow ACMA treatment instructions.
Causes immense pain and sickness, and a host of other severe side effects, so much so that many patients drop out of chemotherapy and would rather die than continue their treatments. No pain or suffering is ever caused by ACMA cancer treatments. If the cancer, or prior orthodox treatments, cause pain, ACMA cancer treatments frequently reduce the pain and sickness within hours or days.
Orthodox treatment has very high relapse rate after remission. Patients usually will die after the cancer relapses. So far, after ACMA cancer treatment help cancer patients achieve remission, no cancer relapse has occurred.
Orthodox treatment cannot prevent cancer from relapsing. ACMA cancer treatments can prevent cancer from relapsing.
According to NIH statistics, cancer patient's 5-year survival rate after receiving chemotherapy is 2.1%. For stage I, II, III cancer patients after receiving ACMA cancer treatments, the 5-year survival rate is 100%. For stage IV cancer patients after receiving ACMA cancer treatments, the 5-year survival rate is about 80%.
(Data on orthodox treatment is unavailable) For stage I, II, III cancer patients after receiving ACMA cancer treatments, the 5-year remission rate is 100%.
(Data on orthodox treatment is unavailable) For stage I, II, III cancer patients after receiving ACMA cancer treatments, the 5-year cancer relapse rate is zero.
(Data on orthodox treatment is unavailable) For stage I, II, III cancer patients after receiving ACMA cancer treatments, the 5-year cure rate is 100%.

ACMA Liver Cancer Treatment has obtained very encouraging treatment outcomes. ACMA Liver Cancer Treatment can reduce and normalize the elevated liver cancer marker alpha-fetoprotein (AFP), reduce and normalize the liver enzymes, improve patient’s liver function, and improve patient’s overall blood test results.

ACMA Liver Cancer Treatment can improve liver cancer patient’s cirrhosis condition, improve patient’s jaundice symptom, and improve liver cancer patient’s other signs and symptoms.

ACMA Liver Cancer Treatment can shrink the liver tumor, and save the liver cancer patient’s life.

ACMA Liver Cancer Treatment is natural, safe, and has no side effect.

Case Report

ACMA Cancer Center has treated a liver cancer patient. The treatment results are as follows.

  1. Before ACMA Cancer Center TreatmentThe patient was a 51 years old male. Soon before starting the ACMA cancer treatment, the patient’s lab test of liver cancer marker alpha-fetoprotein (AFP) was 2726 (reference: < 6.1 ng/ml). Cancer tumor size was 7.8 cm, which was too big and had missed the timing for surgery.Because the tumor was too big when the liver cancer was found, it was too late to do surgery. His oncologist predicted he would die within 3 months. The patient did not receive any Western Medicine treatments (surgery, chemo, or radiation therapy, etc.), and only received the ACMA Cancer Center treatments.
  2. Three Months After ACMA Cancer Center TreatmentAfter 3 months ACMA treatments, the patient’s AFP dropped to 6.0 (reference: < 6.1 ng/ml), which is technically normal according to Western Medicine’s standards.
  3. Six Months After ACMA Cancer Center TreatmentAfter 6 months ACMA treatments, the patient’s AFP became 3.2 (reference: < 6.1 ng/ml), which had been continuously improving.
  4. Eight Months After ACMA Cancer Center TreatmentAfter 8 months ACMA cancer treatment, the patient’s cancer tumor size was shrunk to 3 cm.The patient’s signs and symptoms had been improved too since ACMA cancer treatments.
  5. One Year After ACMA Cancer Center TreatmentOne year has passed since the patient got the liver cancer. The patient has not died as predicted by his oncologist and the WHO statistics. The patient has gone back to work. He can play golf, etc. sports and has resumed other routine daily activities.
  6. Oncologist’s OpinionThe patient’s oncologist said he is an exception because most liver cancer patients have to have more chemotherapy treatments and maybe the same kind of treatments for the rest of their lives. Due to this reason, the oncologist has been supporting the patient to continue the treatments at ACMA Cancer Center.
  7. Side EffectsThe patient has not had any side effects during the treatments at ACMA Cancer Center.
  8. PrognosisAccording to statistics from the World Health Organization (WHO), almost all liver cancer patients will die in a year after being diagnosed as liver cancer. The average life span of liver cancer patients is about 4 to 6 months.Now more than 3 years have passed since this patient was diagnosed with liver cancer. Currently, the patient has gone back to work and resumed all normal daily activities. This ACMA cancer patient’s prognosis is much more optimistic than the prognosis of other liver cancer patients who are under Western Medicine treatments (surgery, chemo, or radiation therapy).